Invest now

Unichem Laboratories share price

High risk
  • 57%Low risk
  • 57%Moderate risk
  • 57%Balanced risk
  • 57%High risk
  • 57%Extreme risk
Analyse on
AI
  • ₹520.50(-0.96%)
    October 14, 2026 15:24:23 PM IST
    • NSE
    • BSE
  • Vol : 29.06 K (NSE + BSE)
    Last 20 day avg : 315.93 K
Unichem Laboratories is trading -0.96% lower at Rs 520.50 as compared to its last closing price. Unichem Laboratories has been trading in the price range of 527.80 & 518.00. Unichem Laboratories has given 19.12% in this year & -3.97% in the last 5 days. Unichem Laboratories has TTM P/E ratio 10.67 as compared to the sector P/E of 33.33.The company posted a net profit of 41.47 Crores in its last quarter.Listed peers of Unichem Laboratories include Aurobindo Pharma (-1.37%), Neuland Laboratories (-0.91%), Pfizer (-3.21%).The Mutual Fund holding in Unichem Laboratories was at 8.65% in 30 Sep 2026. The MF holding has decreased from the last quarter. The FII holding in Unichem Laboratories was at 2.70% in 30 Sep 2026. The FII holding has increased from the last quarter.
  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Loading...
Screen on
Try Now
Key Metrics

Updated on 14 Oct 2026, 11:14 PM IST

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.20
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.18
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    0.25
    Indicates undervaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
518.00
Highest
527.80
52 week range
Lowest
280.00
Highest
685.95
Unichem Laboratories Peers
Return Comparison
Peers Comparison
Names
Price%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Aurobindo Pharma		1,659.90-1.3795,506.9725.092.350.262.89
Neuland Laboratories		20,167.50-0.9125,775.1264.2812.620.1813.90
Pfizer		3,925.55-3.2117,954.2827.534.971.640.86
Jagsonpal Pharmaceuticals		223.800.451,478.4134.275.431.122.39
Themis Medicare		108.001.27991.48632.192.540.455.48
Mutual Fund Ownership
View all
DSP Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 50.98
  • % of AUM 1.72
HDFC Small Cap Fund Growth
3/5
  • Amount Invested (Cr.) 327.41
  • % of AUM 0.96
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
NA
  • Amount Invested (Cr.) 14.42
  • % of AUM 0.26
Quant Value Fund Regular Growth
4/5
  • Amount Invested (Cr.) 3.66
  • % of AUM 0.20
Bandhan BSE Healthcare Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.02
  • % of AUM 0.10
Unichem Laboratories Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-08-11Quarterly Results
2026-05-22Audited Results
2026-02-05Quarterly Results
2025-11-11Quarterly Results
2025-08-04Quarterly Results
About the company Unichem Laboratories
  • IndustryMajor Drugs
  • ISININE351A01035
  • BSE Code506690
  • NSE CodeUNICHEMLAB
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
  • Management Info
  • Sanjay JainChief Financial Officer
  • Pradeep BhandariCompliance Officer, Company Secretary and Head Legal
  • Pabitrakumar BhattacharyyaManaging Director, Executive Director
Unichem Laboratories Share Price FAQs

Unichem Laboratories is trading at 520.50 as on Wed Oct 14 2026 09:54:23. This is -0.96% lower as compared to its previous closing price of 525.55.

The market capitalization of Unichem Laboratories is 3664.62 Cr as on Wed Oct 14 2026 09:54:23.

The 52 wk high for Unichem Laboratories is 685.95 whereas the 52 wk low is 280.00

Unichem Laboratories can be analyzed on the following key metrics -

  • TTM P/E: 10.67
  • Sector P/E: 33.33
  • Dividend Yield: 0.00%
  • D/E ratio: -

Unichem Laboratories reported a net profit of 252.84 Cr in 2026.

The Mutual Fund Shareholding was 8.65% at the end of 30 Sep 2026.

Quick Links
EQUITY QUICK LINKS
Unichem Laboratories QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Home/Market/Market Stats/  Unichem Laboratories share price
✕

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

✕

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.